Targeting a New Hormone Helps to Prevent Type 1 Diabetes
A publication authored by Harvard University scientists has found that targeting a new hormone, FABP4, can enhance beta cell function…
Stem Cell Replacement Therapy: Its Time has Begun
ViaCyte has results on its second stem cell-based technology, providing evidence of stem cells secreting insulin in response to meal…
Progress Toward Cures: Thoughts at Year’s End from Breakthrough T1D’s CEO
Breakthrough T1D CEO Aaron Kowalski, Ph.D., weighs in on the exciting news surrounding stem cell-derived beta cell replacement therapies, now…
NFL Superstars Wear Their Hearts on Their Cleats
NFL Superstars across the league are donning custom designed cleats in support of Breakthrough T1D.
Find Your Something
A resident physician and T1D dad—who also lives with an autoimmune disease—shares his call to action to support Breakthrough T1D…
Managing Diabetes During the Holidays
What’s your strategy for managing your diabetes during the holidays? The Breakthrough T1D-Beyond Type 1 Alliance offers tips to ensure…
NFL Miami Dolphins and Breakthrough T1D Ambassador Blake Ferguson Snaps Hard for Cures!
NFL long snapper for the Miami Dolphins Blake Ferguson is a T1D Champion! Learn how he's helping Breakthrough T1D win…
First-in-Human Gene-Edited Stem Cell Trial? Check.
ViaCyte, a beta cell replacement company long supported by Breakthrough T1D, and CRISPR Therapeutics have a new first: Gene-editing for…
The Bonds of Family and the Power of Fiction
Author Eve Yohalem interviews her sister about life with type 1 diabetes and the power of fiction to make diabetes…
First-in-Human T1D Vaccine Trial Reports Positive Results
A first-in-human study of the coxsackie B vaccine—made by Breakthrough T1D-funded researchers Drs. Hyoty and Knip—reports positive results.
